Inflammation

Items 291-300 of 305

per page
Set Descending Direction
  1. TREX1 (human) (rec.) (His) (active) (10µg)
    BBL-2262
    BBL-2262-C01010 µg
    CHF 1'227.00
    TREX1 (human) (rec.) (His) (active) (10µg)
  2. TREX1 (human) (rec.) (His) (active) (1µg)
    BBL-2260
    BBL-2260-C0011 µg
    CHF 441.00
    TREX1 (human) (rec.) (His) (active) (1µg)
  3. TRIS with EDTA [TE Buffer] (100x) Endotoxin-free (sterile)
    IAX-900-005
    IAX-900-005-LD151.5 ml
    CHF 56.00
    IAX-900-005-L01010 ml
    CHF 124.00
    IAX-900-005-30103 x 10 ml
    CHF 248.00
  4. Umifenovir . hydrochloride
    CAS  131707-23-8
    AG-CR1-3718
    AG-CR1-3718-M01010 mg
    CHF 60.00
    AG-CR1-3718-M05050 mg
    CHF 180.00
    AG-CR1-3718-M250250 mg
    CHF 540.00
    Umifenovir . hydrochloride
  5. Umifenovir Lipodisq™ Sterile Solution
    CAS  131707-23-8
    IAX-700-106
    IAX-700-106-L0011 ml
    CHF 244.00
    Umifenovir Lipodisq™ Sterile Solution
  6. Ursodeoxycholic acid
    CAS  128-13-2
    AG-CN2-0411
    AG-CN2-0411-G0011 g
    CHF 52.00
    AG-CN2-0411-G0055 g
    CHF 156.00
    Ursodeoxycholic acid
  7. Vincristine . sulfate
    CAS  2068-78-2
    AG-CN2-0446
    AG-CN2-0446-M0055 mg
    CHF 55.00
    AG-CN2-0446-M02525 mg
    CHF 180.00
    Vincristine . sulfate
  8. Vinpocetine
    CAS  42971-09-5
    AG-CN2-0454
    AG-CN2-0454-M02020 mg
    CHF 45.00
    AG-CN2-0454-M100100 mg
    CHF 95.00
    AG-CN2-0454-G0011 g
    CHF 120.00
    Vinpocetine
  9. VIP (human, mouse, rat) . acetate [RLF-100]
    CAS  1444827-29-5 | 40077-57-4 (free base)
    AG-CP3-0041
    AG-CP3-0041-M0011 mg
    CHF 90.00
    AG-CP3-0041-M0055 mg
    CHF 210.00
    AG-CP3-0041-M02525 mg
    CHF 430.00
    VIP (human, mouse, rat) . acetate [RLF-100]
  10. Withaferin A
    CAS  5119-48-2
    AG-CN2-0490
    AG-CN2-0490-M0011 mg
    CHF 90.00
    AG-CN2-0490-M0055 mg
    CHF 270.00
    AG-CN2-0490-M01010 mg
    CHF 380.00
    Withaferin A

Items 291-300 of 305

per page
Set Descending Direction
© 2017 Adipogen Life Sciences. Pictures: © 2012 Martin Oeggerli. All Rights Reserved.